SCHEMBL3973274

SCHEMBL3973274

NNC(=O)c1occc1-c1cccc(OCCc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.51
SIRT2 Q8IXJ6 3/20 0.46
MAOA P21397 4/20 0.45
MAOB P27338 4/20 0.45
FFAR1 O14842 3/20 0.44
F9 P00740 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975306 0.90 SMPD1 (0.49) NR1H4MAOBALDH1A1SMN1; SMN2HDAC4
SCHEMBL27624422 0.88 NR1H4 (0.52) NR1H4SIRT2MAOAMAOBFFAR1
SCHEMBL3978096 0.84 MEN1 (0.50) FFAR1KDM4EALDH1A1LMNAGAA
SCHEMBL3976205 0.81 LTA4H (0.39) KDM4EALDH1A1LMNAGAAHTT
SCHEMBL3977608 0.80 ALDH1A1 (0.47) MAOAMAOBFFAR1KDM4EALDH1A1
SCHEMBL3978696 0.80 PTGER4 (0.44) SIRT2MAOBFFAR1KDM4ESMN1; SMN2
SCHEMBL3977184 0.80 GPR132 (0.46) NR1H4ALDH1A1GAAHTTSMN1; SMN2
SCHEMBL3975736 0.79 NR1H4 (0.45) NR1H4
SCHEMBL3975741 0.79 NR1H4 (0.38) NR1H4SIRT2MAOAMAOBFFAR1
SCHEMBL4285451 0.78 MAPT (0.43) KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 NR1H4 288/4885SIRT2 210/4885MAOA 1046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.